Dongha Kim,1,5 Hye Jin Nam,1,5,6 Wonhwa Lee,2,7 Hwa Young Yim,3 Jun-Yeong Ahn,1 Se Won Park,1 Hi-Jai R. Shin,1 Reynold Yu,4 Kyoung-Jae Won,4 Jong-Sup Bae,2 Keun Il Kim,3,* and Sung Hee Baek1,8,*
1Creative Research Initiatives Center for Epigenetic Code and Diseases, Department of Biological Sciences, Seoul National University, Seoul 08826, South Korea
2College of Pharmacy, CMRI, Research Institute of Pharmaceutical Sciences, BK21 Plus KNU Multi-Omics Based Creative Drug Research Team, Kyungpook National University, 80 Dahak-ro, Buk-gu, Daegu 41566, South Korea
3Department of Biological Sciences, Cellular Heterogeneity Research Center, Sookmyung Women’s University, Seoul 04310, South Korea
4The Institute for Diabetes, Obesity, and Metabolism, Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
5These authors contributed equally
6Present address: Korea Research Institute of Chemical Technology, Daejeon 34114, South Korea
7Present address: Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, South Korea
8Lead Contact
*Correspondence : Keun Il Kim, Sung Hee Baek